California State Teachers Retirement System (CalSTRS)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $201M | Sell |
3,317,201
-77,660
| -2% | -$4.53M | 0.21% | 80 |
|
|
2025
Q4 | $183M | Sell |
3,394,861
-39,885
| -1% | -$1.92M | 0.18% | 96 |
|
|
2025
Q3 | $155M | Buy |
3,434,746
+32,866
| +1% | +$1.53M | 0.16% | 110 |
|
|
2025
Q2 | $157M | Buy |
3,401,880
+71,029
| +2% | +$3.49M | 0.17% | 105 |
|
|
2025
Q1 | $203M | Sell |
3,330,851
-11,833
| -0.4% | -$690K | 0.25% | 79 |
|
|
2024
Q4 | $189M | Sell |
3,342,684
-148,047
| -4% | -$8.27M | 0.22% | 79 |
|
|
2024
Q3 | $181M | Buy |
3,490,731
+6,248
| +0.2% | +$293K | 0.21% | 86 |
|
|
2024
Q2 | $145M | Buy |
3,484,483
+49,970
| +1% | +$2.24M | 0.18% | 103 |
|
|
2024
Q1 | $186M | Sell |
3,434,513
-13,446
| -0.4% | -$685K | 0.24% | 81 |
|
|
2023
Q4 | $177M | Buy |
3,447,959
+60,431
| +2% | +$3.17M | 0.24% | 78 |
|
|
2023
Q3 | $197M | Sell |
3,387,528
-119,559
| -3% | -$7.33M | 0.3% | 57 |
|
|
2023
Q2 | $224M | Sell |
3,507,087
-227,574
| -6% | -$15.3M | 0.32% | 52 |
|
|
2023
Q1 | $259M | Sell |
3,734,661
-44,565
| -1% | -$3.14M | 0.39% | 47 |
|
|
2022
Q4 | $272M | Buy |
3,779,226
+64,074
| +2% | +$4.83M | 0.43% | 42 |
|
|
2022
Q3 | $264M | Sell |
3,715,152
-81,126
| -2% | -$5.88M | 0.45% | 39 |
|
|
2022
Q2 | $292M | Sell |
3,796,278
-68,375
| -2% | -$5.21M | 0.46% | 39 |
|
|
2022
Q1 | $282M | Sell |
3,864,653
-250,663
| -6% | -$16.8M | 0.37% | 52 |
|
|
2021
Q4 | $257M | Buy |
4,115,316
+135,189
| +3% | +$7.93M | 0.3% | 58 |
|
|
2021
Q3 | $236M | Buy |
3,980,127
+41,954
| +1% | +$2.76M | 0.3% | 59 |
|
|
2021
Q2 | $263M | Sell |
3,938,173
-411,774
| -9% | -$26.8M | 0.33% | 53 |
|
|
2021
Q1 | $275M | Sell |
4,349,947
-35,118
| -0.8% | -$2.18M | 0.36% | 53 |
|
|
2020
Q4 | $272M | Buy |
4,385,065
+27,783
| +0.6% | +$1.71M | 0.38% | 49 |
|
|
2020
Q3 | $263M | Sell |
4,357,282
-121,156
| -3% | -$7.29M | 0.42% | 45 |
|
|
2020
Q2 | $263M | Buy |
4,478,438
+21,620
| +0.5% | +$1.29M | 0.46% | 41 |
|
|
2020
Q1 | $248M | Buy |
4,456,818
+28,425
| +0.6% | +$1.74M | 0.54% | 33 |
|
|
2019
Q4 | $284M | Buy |
4,428,393
+1,599,139
| +57% | +$91.6M | 0.48% | 36 |
|
|
2019
Q3 | $143M | Sell |
2,829,254
-68,320
| -2% | -$3.21M | 0.28% | 63 |
|
|
2019
Q2 | $131M | Buy |
2,897,574
+15,294
| +0.5% | +$712K | 0.26% | 67 |
|
|
2019
Q1 | $138M | Buy |
2,882,280
+135,397
| +5% | +$6.74M | 0.28% | 64 |
|
|
2018
Q4 | $143M | Buy |
2,746,883
+27,755
| +1% | +$1.49M | 0.32% | 59 |
|
|
2018
Q3 | $169M | Buy |
2,719,128
+1,298
| +0% | +$77K | 0.33% | 57 |
|
|
2018
Q2 | $150M | Sell |
2,717,830
-181,375
| -6% | -$9.8M | 0.31% | 59 |
|
|
2018
Q1 | $183M | Sell |
2,899,205
-89,427
| -3% | -$5.75M | 0.39% | 47 |
|
|
2017
Q4 | $183M | Buy |
2,988,632
+147,920
| +5% | +$9.25M | 0.38% | 45 |
|
|
2017
Q3 | $181M | Sell |
2,840,712
-256,670
| -8% | -$15M | 0.4% | 46 |
|
|
2017
Q2 | $173M | Sell |
3,097,382
-230,891
| -7% | -$12.6M | 0.37% | 46 |
|
|
2017
Q1 | $181M | Sell |
3,328,273
-152,500
| -4% | -$8.36M | 0.37% | 47 |
|
|
2016
Q4 | $203M | Sell |
3,480,773
-92,800
| -3% | -$5.07M | 0.41% | 42 |
|
|
2016
Q3 | $193M | Buy |
3,573,573
+30,000
| +0.8% | +$1.93M | 0.4% | 44 |
|
|
2016
Q2 | $261M | Buy |
3,543,573
+1,909
| +0.1% | +$135K | 0.56% | 33 |
|
|
2016
Q1 | $226M | Buy |
3,541,664
+452,506
| +15% | +$28.5M | 0.48% | 40 |
|
|
2015
Q4 | $213M | Buy |
3,089,158
+49,245
| +2% | +$3.25M | 0.52% | 34 |
|
|
2015
Q3 | $180M | Sell |
3,039,913
-4,600
| -0.2% | -$292K | 0.47% | 36 |
|
|
2015
Q2 | $203M | Sell |
3,044,513
-54,671
| -2% | -$3.6M | 0.49% | 37 |
|
|
2015
Q1 | $200M | Sell |
3,099,184
-51,523
| -2% | -$3.23M | 0.47% | 39 |
|
|
2014
Q4 | $186M | Buy |
3,150,707
+29,560
| +0.9% | +$1.67M | 0.44% | 41 |
|
|
2014
Q3 | $160M | Buy |
3,121,147
+93,655
| +3% | +$4.68M | 0.4% | 44 |
|
|
2014
Q2 | $147M | Buy |
3,027,492
+39,500
| +1% | +$1.95M | 0.37% | 45 |
|
|
2014
Q1 | $155M | Buy |
2,987,992
+14,100
| +0.5% | +$750K | 0.41% | 43 |
|
|
2013
Q4 | $158M | Buy |
2,973,892
+20,400
| +0.7% | +$1.04M | 0.43% | 40 |
|
|
2013
Q3 | $137M | Buy |
2,953,492
+91,219
| +3% | +$4M | 0.41% | 42 |
|
|
2013
Q2 | $128M | Buy |
+2,862,273
| New | +$124M | 0.42% | 39 |
|
Other funds holding BMY
VCM
VPM
California State Teachers Retirement System (CalSTRS)'s BMY Position: Q1 2026 in Review
California State Teachers Retirement System (CalSTRS) reduced its Bristol-Myers Squibb (BMY) stake by 2.3% in Q1 2026, selling an estimated $4.53M and leaving 3,317,201 shares worth $201M. The position accounts for 0.21% of the portfolio, ranked #80.
California State Teachers Retirement System (CalSTRS) first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $292M in Q2 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- California State Teachers Retirement System (CalSTRS) held 3,317,201 shares of Bristol-Myers Squibb worth $201M as of Q1 2026.
- California State Teachers Retirement System (CalSTRS) sold 77,660 Bristol-Myers Squibb shares in Q1 2026, an estimated $4.53M.
- Bristol-Myers Squibb made up 0.21% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q1 2026, its #80 holding.
- California State Teachers Retirement System (CalSTRS) first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- California State Teachers Retirement System (CalSTRS)'s Bristol-Myers Squibb position peaked at $292M in Q2 2022.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.